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Conventional approaches to site mapping have so
far failed to identify the laulimalide binding site on
microtubules. Using mass shift perturbation analysis
and data-directed docking, we demonstrate that
laulimalide binds to the exterior of the microtubule
on b-tubulin, in a region previously unknown to sup-
port ligand binding and well removed from the pacli-
taxel site. Shift maps for docetaxel and laulimalide
are otherwise identical, indicating a common state
of microtubule stability induced by occupancy of
the distinct sites. The preferred binding mode high-
lights the penetration of the laulimalide side chain
into a deep, narrow cavity through a unique confor-
mation not strongly populated in solution, akin to a
‘‘striking cobra.’’ This mode supports the develop-
ment of a pharmacophore model and reveals the
importance of the C1–C15 axis in the macrocycle.
INTRODUCTION
Paclitaxel and its mimetics represent a standard of care in the
treatment of solid tumors of the breast, ovary, and lung (de
Bree et al., 2006; Henderson et al., 2003; Paz-Ares et al., 2008).
These drugs bind to microtubules in a manner that distorts the
dynamic assembly properties of this protein polymer, leading to
mitotic arrest and variable cell fates, including apoptosis. The
pivotal role of microtubules in cell division has rendered the
assembly unit, the a/b-tubulin dimer, an enduring target for
the development of chemotherapeutic drugs. Clinical inadequa-
cies of the taxoids, including severe and persistent peripheral
neuropathies, drug resistance, and vehicle-related toxicities,
continue to drive new ligand development (Argyriou et al., 2008;
Hunt, 2009; Singer et al., 2005). Unfortunately the diffuse nature
of the taxoid binding site haspresented roadblocks topharmaco-
phore modeling and rational ligand design (Nettles et al., 2004),
prompting a search for alternative therapeutic entry points.
Studies with a new class of polyketide macrolide isolated from
deep-sea sponges have proposed the existence of a nontaxoid
site that, when bound, induces microtubule stabilization in aChemistry & Biology 17,fashion similar to the taxanes (Gaitanos et al., 2004; Hamel
et al., 2006; Pryor et al., 2002). Laulimalide, also known as fijiano-
lide B (Figure 1), is representative of this new class of agents.
Laulimalide has demonstrated extremely high potency against
solid tumor cancer cell lines (Mooberry et al., 1999). It increases
the density of interphase microtubules and causes the formation
of thick, short microtubule bundles in the cytoplasm of inter-
phase cells and abnormal mitotic spindles (Mooberry et al.,
2004). This leads to G2/M arrest and eventual cell death. While
the promise of a more effective alternative to paclitaxel exists,
the clinical future of laulimalide as a monotherapy is uncertain.
One study has demonstrated efficacy in a human colon cancer
model and limited general toxicity (Johnson et al., 2007), while
another has demonstrated severe toxicity and minimal tumor
inhibition (Liu et al., 2007). However, in combination with other
tubulin-targeting antimitotic agents it shows significant synergy
at the level of cytotoxicity and antiproliferative activity (Clark
et al., 2006). Although the mechanism of this synergy has yet
to be established, it may derive from the combined effects on
tubulin dynamics (Gapud et al., 2004; Hamel et al., 2006; Jordan
and Wilson, 2004). The ligand class in general also appears less
susceptible to P-glycoprotein (Pgp)-mediated drug resistance
than the taxanes (Clark et al., 2006; Mooberry et al., 1999).
Collectively, these findings argue for the continued exploration
of laulimalide and the minimization of adverse toxicological
properties through ligand design. A thorough exploration will
require knowledge of the ligand binding site and a detailed
understanding of structure-activity relationships, to permit the
development of analogs with altered toxicity profiles and opti-
mized synergistic effects. In addition, the discovery of a novel
site for induction of microtubule stability will provide new oppor-
tunities to study molecular mechanisms relevant to cell division,
by offering a new set of chemical probes.
The identification of the paclitaxel binding site was achieved
by tubulin structural analysis using electron crystallography,
but this has not been successful to date for the identification of
the laulimalide site (Thepchatri et al., 2005). Using displacement
studies, laulimalide was unable to inhibit Flutax-2 (a fluorescent
paclitaxel) or [3H] paclitaxel from binding, but this simply indi-
cates that binding is distinct from the paclitaxel site (Pryor
et al., 2002). Early efforts in site identification have involved
peloruside A, a ligand of the same class that has been shown
to compete with laulimalide for binding to microtubules (Gaita-
nos et al., 2004). A computational study has suggested that725–734, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 725
Figure 1. Chemical Structure of Laulimalide
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Laulimalide Binding Modepeloruside A binds to the M-loop on a-tubulin in a region analo-
gous to the paclitaxel site on b-tubulin (Jimenez-Barbero et al.,
2006). However, a recent study in our lab proposed a site on
b-tubulin on the exterior of the microtubule (Huzil et al., 2008).
This was suggested upon an analysis of drug-induced micro-
tubule stability using hydrogen/deuterium (H/D) exchange
methods and mass spectrometry. An external site, if confirmed,
would represent anobviousmeansbywhich endogenous protein
regulators could affect microtubule stability in vivo.
The current study employs a refined mass spectrometry-
based method to discover and characterize the laulimalide
binding mode. The approach is inspired by chemical shift
perturbation (CSP) methods in NMR, which are used extensively
for protein interface mapping and more recently for protein-
ligand interface mapping (Stark and Powers, 2008; Zuiderweg,
2002). In place of chemical shifts, ligand-induced perturbations
of backbone amide H/D exchange rates are used as sensors
for the formation of new interfaces and the allosteric effects of
ligation. While H/D exchange mass spectrometry is used
extensively in the study of protein folding (Engen, 2009; Maier
and Deinzer, 2005), recent advancements promote the
automated analysis of small molecule interactions with large
molecular complexes, as well as extensive protein-protein inter-
actions (Chalmers et al., 2006, 2007; Slysz et al., 2008, 2009).
Here, we describe the application of this mass shift perturbation
(MSP) method for laulimalide binding site determination, and,
together with data-directed computational strategies, we pre-
sent a high-resolution binding mode for the ligand on natural
microtubule assemblies. Using MSP data, we also show that
laulimalide induces a microtubule stability profile that is virtually
indistinguishable fromdocetaxel and suggestive of amechanism
for synergy in tubulin assembly.
RESULTS
Mass Shift Perturbation Analysis
of Ligated Microtubules
Replicate measurements of the ligand-induced perturbation
of H/D exchange were conducted on assembled microtubules
partially stabilized by a nonhydrolyzable analog of GTP
(GMPCPP), to prevent depolymerization events during our
analyses (Hyman et al., 1992). Ligand binding at the paclitaxel
site induces further stabilization of microtubules, manifesting as726 Chemistry & Biology 17, 725–734, July 30, 2010 ª2010 Elsevier Lreduced mass shifts in a large set of peptides monitored in the
H/D exchange experiment (see Figures S1A and S1B available
online), which is consistent with earlier findings (Huzil et al.,
2008; Xiao et al., 2006). Experiments with laulimalide-stabilized
microtubules revealed similarly extensive shift perturbations,
rendering an objective localization of the binding site difficult
(Figures S1C and S1D). We hypothesized that perturbations
unique to the binding site could be detected more readily by
suppressing common allosteric effects of ligand binding, using
a stabilizer targeting the paclitaxel binding site. This was based
on the observation that laulimalide binding is not competitive
with fluorescent paclitaxel and does not appear to influence
paclitaxel-tubulin stoichiometry (Pryor et al., 2002). To test this,
microtubules were stabilized with a combination of laulimalide
and docetaxel, the latter a hydroxylated paclitaxel binding to
the taxoid site (Ringel andHorwitz, 1991). The resultingmass shift
data were then compared with similar analyses of microtubules
stabilizedwith each ligand separately andmapped to the regions
in sequence space (Figure 2).Wenote that a direct comparison of
shift data from laulimalide and docetaxel stabilized microtubules
provides a similar opportunity, but referencing to a coligated,
stabilized form provides reduced noise in the differential shift
map and offers greater discrimination power (not shown).
The shift map arising from docetaxel applied to laulimalide-
stabilized microtubules validates this strategy, as the taxoid
binding site is clearly highlighted by large negative mass shifts
(Figures 2A and 3B). This represents 7% of the peptides moni-
tored, where docetaxel stabilization alone induced significant
shifts in over 17% of peptides (Figure S1A). Two negative
mass shifts arise from peptides defining a surface composed
of the M-loop (b266–280) and the H6–H7 loop region (b213–
230) (Figure 3A). The M-loop contains critical residues that are
involved in the stabilization of the oxetane ring of the taxanes.
In the H6-H7 loop region, Leu217 and Leu219make hydrophobic
contact with the 2-phenyl ring, assisting in stabilization (Lowe
et al., 2001). As in an earlier study, the loop between bS9 and
bS10 does not show significant labeling, even though this region
appears in close contact with docetaxel based on established
structures (Huzil et al., 2008).
Similarly, the shift perturbations arising from laulimalide applied
todocetaxel-stabilizedmicrotubules represent5%of thepeptides
monitored (Figures 2C and 3B), where laulimalide stabilization
alone caused shifts in at least 21% of the peptides (Figure S1C).
Mapping this reduced set of perturbations to structure highlights
a groove defined by the C-terminal ends of helices bH10 and
bH9 on its sides and bH9’ at its end (Figure 3B, boxed region).
This region represents negative shifts for five overlapping pep-
tides, defining a contiguous patch of solvent-accessible surface
area that can be uniquely identified as the laulimalide binding
site, as the allosteric effects of each ligand and their combination
are identical under saturating conditions (see Supplemental
Experimental Procedures). We note that the region encompasses
the proposed site for peloruside A (Huzil et al., 2008).
Data-Directed Docking of Laulimalide
Computational routines for receptor-ligand modeling were then
implemented to orient the ligand within the laulimalide binding
site identified through the shift perturbation analysis. As the
bound conformation of laulimalide is currently unknown, a largetd All rights reserved
Figure 2. Mass Shift Perturbation Data
between Singly and Doubly Ligated Micro-
tubules
Mass shift perturbation data from analyses of
doubly ligated microtubules relative to the singly
ligated state.
(A) Scatterplot of replication MSP data for
a comparison of doubly ligated microtubules with
laulimalide-stabilized microtubules, highlighting
the perturbations unique to docetaxel.
(B) Significant changes in (A) mapped to their loca-
tions in tubulin sequence.
(C) Scatterplot of replication MSP data for
a comparison of doubly ligated microtubules with
docetaxel-stabilized microtubules, highlighting
the perturbations unique to laulimalide.
(D) Significant changes in (C) mapped to their loca-
tions in tubulin sequence. Each point in (A) and (C)
represents the shift perturbation of a single
peptide in millimass units (mmu). The horizontal
dotted lines represent a ±2 SD cutoff based on
noise in DD measurements and the vertical dotted
line represents a 1-p cutoff value of 0.95. Green
represents positive mass shifts resulting from
single ligation and red represents negative mass
shifts resulting from single ligation. The sequence
maps (B and D) are arranged with a-tubulin on
the bottom and b-tubulin on the top.
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solution conformers and an additional 1500 conformers gener-
ated from this starting set, to adequately sample the conforma-
tional space of the compound (see Experimental Procedures).
These conformers were docked into an ensemble of tubulin
structures to permit the sampling of a realistic degree of back-
bone diversity and principal side chain motions. As laulimalide
binds to microtubules prestabilized with paclitaxel-site ligands,
PDB entries 1JFF (Lowe et al., 2001), 1TUB (Nogales et al.,
1998), and 1TVK (Nettles et al., 2004) were used for this purpose;
these contain bound taxoid ligands. The set was supplemented
with 1SA0 (Ravelli et al., 2004), which represents a colchicine
and RB3/stathmin-stabilized tubulin structure.
The resulting poses for all conformers in the library were
ranked by the lowest energy corresponding to the most popu-
lated cluster. That is, once all poses from each conformer entry
were clustered, we filtered all of the clusters so that only those
containing at least 25% of the total population are considered
as top hits (Figure S2A), leading to the selection of two lowest
energy binding modes, 1 and 2 (Figures S2B and S2C). The
two modes have approximately inverted orientations within the
groove, where mode 1 has a binding energy 2 kcal/mol lower
thanmode 2 based on AUTODOCK calculations. A blind docking
exercise confirmed that these poses strongly favored the site
identified by mass shift perturbation over any other region of
the protein (e.g., Figure S3). There were no meaningful differ-
ences detected among the PDB entries with respect to the
binding modes and binding energies.
MD Simulations and Refinement
MD simulations were then conducted from the lowest energy
conformation for each mode. The trajectories of the simulationsChemistry & Biology 17,were used to perform anMM-PBSA analysis in order to calculate
the relative binding energies and binding free energies (see
Experimental Procedures). The two binding modes showed
stability over the course of the simulation and neither deviated
from the binding site or showed substantial fluctuations during
the simulation. However, the MM-PBSA analysis (Table 1) high-
lights that mode 1 is strongly preferred over mode 2, returning
binding free energies that correlate with solution data (Mooberry
et al., 2004; Pryor et al., 2002). Consequently, mode 1 was used
to determine the preferred conformation of the ligand within the
binding site. We used clustering analysis to classify all possible
binding poses into groups of similar conformations. To estimate
the optimal number of clusters from the trajectory, this number
was increased until sufficient convergence was achieved based
on clusteringmetrics (see Experimental Procedures). Comparing
the two metrics that were used in this study, a local minimum in
DBI occurred at a cluster count of five. Although the SSR/SST
ratio (where SSR is the sum-of-squares regression from each
cluster summed over all clusters and SST is the total sum of
squares ratio) did not saturate at this number of clusters, its value
approached the convergence ratio. Thus, five clusters were
taken to represent the laulimalide-tubulin simulation, where
two of these clusters accounted for more than 75% of the whole
trajectory. As the resulting poses from these two clusters are not
significantly distinct from a structural perspective, the dominant
one is shown in Figure 4. Finally, these simulations were also
conducted in the presence of paclitaxel as stabilizer. Binding
free energies were similar for the paclitaxel-free and paclitaxel-
bound form although the enthalpy/entropy contributions were
considerably different (Table 1). Upon coligation, laulimalide
adopts a narrower profile within the binding site, although key
receptor contacts are maintained (see below).725–734, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 727
Figure 3. Differential MSP Data Mapped to a/b-Tubulin
Significantly perturbed mass shifts mapped to tubulin structure PDB 1JFF resulting from (A) docetaxel on a laulimalide-stabilized microtubule and (B) laulimalide
on a docetaxel-stabilized microtubule. Corresponding histograms portray shift values per peptide (a-tubulin peptides shown with asterisk, ±1 SD). Red
represents negative mass shifts and green positive mass shifts. Nucleotides are shown in yellow sticks, paclitaxel in yellow spheres, and the laulimalide site
demarcated by the black square.
Chemistry & Biology
Laulimalide Binding ModeColigation Shows Assembly Synergy
and Does Not Affect Stoichiometry
A turbidometric assay confirmed that laulimalide and docetaxel
act with positive overall synergy upon MT assembly under satu-
rating conditions (Figure S4), as was noted in other combinations
of laulimalide with taxoid site ligands (Hamel et al., 2006; Pryor
et al., 2002). Additionally, coligation of laulimalide and docetaxel
does not appear to influence the stoichiometry of binding. The
mass shifts for peptides in both binding sites were compared
relative to single ligand data and are equivalent, within the error
of themeasurements (Figure S5). As stoichiometry is 1:1 for each
ligand separately, we conclude that under saturating conditionsTable 1. Influence of Paclitaxel Binding on Possible Laulimalide
Binding Modes
Modea A B
Paclitaxelb (with Zn2+) Y N Y N
Molecular mechanics energy 37 29 21 25
Entropy (TSSolute) 26 19 18 20
Binding free energy 11 10 3 5
a A-mode refers to ‘‘side chain in’’ orientation and B-mode to ‘‘side chain
out’’ orientation. All energies in kcal/mol.
b Paclitaxel binding accompanied by Zn2+ to represent the PBD 1JFF
tubulin structure (Lowe et al., 2001).
728 Chemistry & Biology 17, 725–734, July 30, 2010 ª2010 Elsevier Lthe interaction is 1:1:1 with respect to the ligands and assembled
a/b-tubulin dimer. This is also consistent with earlier findings
(Pryor et al., 2002). It remains possible that the dissociation
constants are influenced upon coligation; however, this was
not tested. A laulimalide titration experiment was conducted
on free tubulin dimer, below the critical concentration for
assembly. No measurable mass shifts were noted in the binding
site up to 10 mM ligand (not shown), indicating that laulimalide
binds preferentially to the assembled state, as with the taxoids
(Diaz et al., 1993; Takoudju et al., 1988).DISCUSSION
The potential of a new, nontaxoid entry point into mitotic regula-
tion and cancer treatment has prompted vigorous activity to
define a pharmacophore around laulimalide, in order to accel-
erate the development of clinically tractable analogs. To date,
this has been ligand-based and indirect (Gollner et al., 2009),
due to the lack of available structural information. There has
been no report of a microtubule-laulimalide structure through
crystallographic methods. While electron crystallography was
used successfully for solving the paclitaxel-tubulin structure,
there are challenges in the application of this technique to the
















B Figure 4. The Laulimalide-Tubulin Binding
Mode Resulting from MSP-Guided Docking
and Simulations
(A) The laulimalide pose resulting from MM-PBSA
analysis, showing an intermolecular hydrogen
bond to N337 and an intramolecular hydrogen
bond between C20 OH and the carbonyl oxygen
of the enoate.
(B) Surface representation of (A), highlighting the
shallow groove under the macrocycle and the
deep cavity surrounding the dihydropyran side
chain. In both (A) and (B), three peptides represent-
ing MSP data are colored in orange, yellow, and
green.
(C) The corresponding region from PBD entry
1JFF, highlighting the reorganization of F294,
Y340, and R306 upon laulimalide binding in (A).
(D) Comparison of the bound conformer of this
study (left) with the crystal structure for the free
ligand (right) (Jefford et al., 1996). Oxygens are in
red, and carbons are in green. The bound con-
former is significantly elongated on the C1–C15
axis relative to the crystal structure, with the
epoxide oriented into the macrocycle. The side
chain orients into the page for the bound con-
former, and out of the page for crystal structure.
See also Figures S1 and S2.
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Laulimalide Binding Modeto form the Zn2+-stabilized sheets necessary for structure deter-
mination (Thepchatri et al., 2005).
To enable receptor-based pharmacophore modeling of com-
plex protein systems, we have developed a mass spectrometric
approach analogous to chemical shift perturbation (CSP) map-
ping by NMR, a method used extensively for interface mapping.
Our method invokes limited deuterium uptake at amide bonds to
facilitate rapid and accurate analysis of perturbed uptake (Slysz
et al., 2008, 2009). We refer to this as ‘‘mass shift perturbation’’
(MSP) mapping. Data-directed docking strategies permit the
orientation of the ligand within the region identified by the map.
These maps are efficiently generated and mined from replicate
data sets using DD – (1-p) plots (Figures 2A and 2C), to identify
meaningful perturbations with accuracy.
This approach was used to identify the laulimalide binding site.
As with NMR-based CSP data, ligand binding induces MSPs in
the mass spectra through the creation of new interfaces as
well as via allosteric effects (Englander et al., 2003; Mandell
et al., 1998). It is not always clear, therefore, which region of
the map represents the binding interface. This is the case for
laulimalide-stabilized microtubules, where ligation led to a very
large set of MSPs dispersed throughout the protein structure.
The same is true of docetaxel, a hydroxylated analog of pacli-
taxel. A coligation strategy permitted a significant simplification
of the MSP maps, enabling ready identification of the ligand
binding sites for both ligands. This is possible as the endpoint
of microtubule stabilization is obviously very similar between
the two ligands, even though the binding sites are distinct. The
localization of the laulimalide site to a groove defined by helices
H9, H9’, and H10 permitted a docking calculation into a muchChemistry & Biology 17,smaller volume, where the resulting gain in efficiency was distrib-
uted over a substantial sampling of laulimalide conformer space.
This is a powerful means of implementing computational dock-
ing, leading to greater accuracy in interaction mapping as was
recently demonstrated with NMR data (Stark and Powers, 2008).
A solution NMR study of laulimalide conformer space could
not define a preferred orientation, as might be expected for a
molecule with significant flexibility (Thepchatri et al., 2005).
Upon docking and refinement by MD simulations, the binding
mode described in the current study presents a conformer quite
unique from the range presented in the study by Thepchatri et al.
(2005). An RMSD (root mean square deviation) fitting of the
bound form against all 15 conformers from Thepchatri et al.
did not demonstrate a clear preference for any solution structure
(not shown), although elements of a cobra motif are preserved
for the macrocycle. The cobra has ‘‘struck’’ however, as the
side-chain is deeply recessed within a long narrow cavity at
the base of the groove defining the site, in an orientation
preserving elements of the stretch motif (Figure 4A).
Although the binding groove exists within PDB 1JFF, which is
a paclitaxel-stabilized tubulin structure, the site is reoriented
upon binding of laulimalide and defines two notable regions
(cf. Figures 4A and 4C). The macrolactone ring is positioned
above a set of hydrophobic residues involving helices H9 and
H10, which adopt a parallel, shifted orientation relative to the
nonliganded form. This promotes improved packing of V333
and F294, where a 90 reorientation of the F294 phenyl group
establishes the entrance to a deep cavity. The conformation of
the macrolactone departs significantly from any of the solution
conformers previously reported with the exception of the higher725–734, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 729
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Laulimalide Binding Modeenergy cobra motif (Thepchatri et al., 2005). Examples of this
motif exhibit an increased width of the macrolactone ring, as
measured by the distance along the C1–C15 axis. Themacrolac-
tone ring of the bound conformer is similarly elongated along this
axis, seemingly facilitated by the inward orientation of the
epoxide (Figure 4D). This leads to a near-maximal separation
between the C15 hydroxyl and the enoate. There are no obvious
polar contacts involving the epoxide or the C5–C9 trans-dihydro-
pyran of the macrolactone, suggesting that the binding energy
contributed by this ring structure is primarily based on van der
Waals contacts.
Ligand binding also promotes a reorganization of the side
chains, providing a well-defined entrance to the narrow cavity.
Both R306 and Y340 rearrange to establish a cation-pi interac-
tion (Gallivan and Dougherty, 1999), promoting the stabilization
of the loops in this region and presenting an orientation of
R306 sufficient to generate polar contacts with the oxygen of
the dihydropyran, in the laulimalide side chain. The hydroxyl
group at C15 in laulimalide participates as a hydrogen bond
acceptor with N337, a residue that also defines the entrance to
the cavity. Interestingly, the C20 hydroxyl group of the side chain
interacts with the C1 carbonyl oxygen of the enoate group via an
internal hydrogen bond and does not appear to interact with
D297. The internal hydrogen bond must be important in stabi-
lizing the orientation of the side chain relative to the macrocycle,
as a result. Validation of these findings through mutagenesis,
though reasonable from a conceptual standpoint, is impractical
for essential proteins such as a/b-tubulin. Previous attempts at
generating recombinant a/b-tubulin has met with limited
success (Katz et al., 1990; Sage et al., 1995; Shah et al., 2001).
However, the binding site and the significance of the residues
lining the cavity have been confirmed in a separate study of
drug-selected mutants (D.L. Sackett, personal communication).
The MSP data set captures the critical contacts defined from
the optimized docking model. Three nonoverlapping peptides
define the site, as shown in Figure 4. The shifts cannot be asso-
ciated with individual residues at this level of resolution, but the
effect is unlikely to arise solely from altered solvent accessibility
(Huyghues-Despointes et al., 1999). Stabilization of the under-
lying secondary structure upon binding would also perturb
labeling, which is likely the case for R306 especially, where the
host peptide does not experience any significant alteration in
solvent accessibility at the backbone amides (not shown). It is
interesting that the parallel site on a-tubulin does not appear to
bind laulimalide, based on a blind docking experiment (Figure S3)
and the absence of significant shift values in this region. A com-
parison of regions shows that, while secondary and tertiary
structure are comparable, sequence similarity in the corre-
sponding H10-loop region is poor and likely does not favor
formation of an effective cleft for laulimalide side chain binding.
The laulimalide binding site is quite distinct from the paclitaxel
binding site in its properties. While both share an underlying
hydrophobic surface stabilizing a significant portion of the
ligand, the paclitaxel site is considerably more diffuse, contrib-
uting to a overall ‘‘promiscuity’’ in binding modes and lack of a
clearly defined pharmacophore (Nettles et al., 2004). Several
ligands of remarkably varied structure bind with high affinity to
the taxoid site. The laulimalide site appears to be well defined,
smaller, and, as existing structure-activity data have shown,730 Chemistry & Biology 17, 725–734, July 30, 2010 ª2010 Elsevier Lless tolerant of significant structural adaptations. While the
shallow hydrophobic groove may be permissive of structural
variation, the regions in and near the cavity clearly are not. This
is affirmed by recent evidence highlighting the contribution of
the side chain to activity (Gollner et al., 2009; Mooberry et al.,
2008). The surprising role of the side chain can be understood
based on dihydropyran interactions with R306 and the steric
requirements of the cavity. For example, replacing the dihydro-
pyran with a cyclohexane dramatically reduced activity in
cytotoxicity assays (Wender et al., 2006). Nearly all modifications
to the side chain have a similarly potent and negative effect on
activity (Mooberry et al., 2008). The importance of the C20
hydroxyl group has been established by a number of labs. Modi-
fications of this group have been explored in order to reduce its
role in destabilizing the epoxide; however, a simple modification
to amethoxy group reduces potency by two orders ofmagnitude
(Gallagher et al., 2004). This highlights the importance of the
internal hydrogen bond to the enoate, which we suggest confers
conformational stability upon the ligand. Isolaulimalide, an
analog with the C20 hydroxyl removed in order to promote the
formation of a des-epoxy structure (Mooberry et al., 2004), is
likely a poor ligand for a similar reason. An acetoxy modification
reduces activity as well but not as strongly, perhaps due to
compensating interactions with D297. The participation of the
enoate in a stabilizing interaction with the C20 hydroxyl offers a
reason why enoate modifications have a significant negative
influence on activity (Gallagher et al., 2004).
Our structural model further points to the significance of the
C15 hydroxyl group, which is also consistent with available
structure-activity data. Replacing the hydroxyl with an acetoxy
group has the mildest effect of all known modifications, as
hydrogen bonding to N337 is likely preserved. As the C15
resides outside of the cavity, it is more tolerant of bulky substit-
uents such as p-nitrobenzoate (Gallagher et al., 2004). Overall,
a general pharmacophore model emerges where the side chain
provides selectivity to the interaction and stabilizes a ring con-
former through a critical internal hydrogen bond. This permits
a positioning of the C15 hydroxyl group for favorable hydrogen
bonding to N337, requiring a ‘‘stretch’’ along the C1–C15 axis
of the macrolactone.
This study defines the first stabilizing binding site on microtu-
bules that is fully removed from the taxoid site. All previously
described small molecule stabilizers are in someway accommo-
datedwithin the expansive taxoid binding site within the lumen of
the microtubule, with the possible exception of cyclostreptin.
This has been shown recently to transiently occupy a type I
pore, but nevertheless still overlaps with the taxoid site on the
lumenal side (Buey et al., 2007). The laulimalide site is located
close to the intradimer interface and directly above the colchi-
cine binding site (Figure 5). While it binds in the vicinity of a
type II pore on the lattice, it would not require a fenestration event
as is likely the case for taxoids (Diaz et al., 2003), and thus the site
would be accessible tomicrotubule-associated proteins (MAPs).
We note further that the laulimalide binding site is adjacent to the
MAP-binding C-terminal E-hook on b-tubulin, and therefore this
site may play a role in mediating MAP-tubulin interactions.
Although the laulimalide site is well removed from the taxoid
site, occupancy at either site induces the same stabilization
state, as reflected in the identical allosteric shift maps for bothtd All rights reserved
Figure 5. Orientation of Laulimalide Relative to Paclitaxel
(A) On the full-length a/b-tubulin dimer, plus end on the right, with the M-loop
indicated with an arrow, and (B) on b-tubulin oriented with the plus-end out of
the page, showing an approximate position of the protofilament contacts
(dashed arc) and the base of the E-hook (box). Laulimalide is shown in
magenta, paclitaxel in yellow and bound nucleotides in green, a-tubulin in
pale green, and b-tubulin in pale cyan.
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should not be taken to indicate an identical mechanism of
stabilization as they represent an ‘‘endpoint’’ view of stabiliza-
tion. In other words, even though the ligand-stabilized MTs are
indistinguishable from the perspective of conformational dy-
namics, the two ligands may yet induce stability in different
ways. There are at least two possible mechanistic interpreta-
tions. Although remote in a structural sense, the laulimalide
site and the taxoid site are relatively close in sequence space;
H9 of the laulimalide binding site is C-terminal to the M-loop,
a critical component of the taxoid binding site (Figure 5). There-
fore, binding of laulimalide may stabilize this loop sufficiently to
permit improved protofilament contact as has been proposed
for paclitaxel. In other words, laulimalide may invoke a nearly
identical mechanism of stabilization. Alternatively, laulimalide
may directly stabilize the intradimer interface. In a previous
study, the stability of the latent laulimalide binding site in the
free tubulin dimer was shown to be sensitive to E-site nucleotide
occupancy, where GDP-binding destabilizes this site relative to
GTP (Bennett et al., 2009). Occupation of this site may thereforeChemistry & Biology 17,return a more GTP-like state and reduced tension in the microtu-
bule lattice. Different mechanisms of stabilization may provide
the basis for the assembly synergy that is observed between
these ligands (Gapud et al., 2004).SIGNIFICANCE
This work confirms the existence and location of a fourth distinct
ligand binding site within a/b-tubulin. The laulimalide site joins
the ranks of the colchicine, vinca, and taxol binding sites, with
properties that directly couple into microtubule assembly and
stability. In this regard, the laulimalide site is unique in its
exposure to the outside surface of the microtubule. Colchicine
is buried within the intradimer interface and the vincas are buried
at the interdimer interface. The taxoids occupy a site that is either
partially or fully exposed to the lumen of the microtubule. Many
microtubule associated proteins and nonspecific basic mole-
cules are thought to interact electrostatically via the tubulin
E-hook; however, reports exist of interactions mediated through
nonelectrostatic interactions, suggesting alternative sites of
interaction (Chernov et al., 2008). The laulimalide binding site
may represent a key domain for such interactions, although
this will require further investigation. More specifically, the
mapping of the laulimalide site will aid in further analog develop-
ment as this site is mined for a novel class of chemical probes
and, ultimately, antimitotic therapies.
Finally, the MSP approach as described extends the concept
of interface mapping, as popularized by the NMR-based chem-
ical shift perturbation method, into highly complex protein
organizations. Both methods are very sensitive to additional
effects such as conformational changes, and both bear a compli-
cated relationship between the shift and its structural basis.
However, mapping is still possible using either method provided
there is a means to discriminate between interfaces and allo-
steric effects (Zuiderweg, 2002). The MSP method strongly
relaxes both the sample amount and purity requirements relative
to CSP methods and should be applicable protein mixtures of
higher complexity. In this context, future work will describe the
application of MSP techniques to the interplay of microtubule
regulatory proteins.EXPERIMENTAL PROCEDURES
Microtubule Preparation and Mass Shift Perturbation
Measurements
Purified bovine brain tubulin (Cytoskeleton Inc., cat. no. TL238-A, lot no. 753)
was reconstituted in 12.5 ml nucleotide free buffer (20 mMKCl, 10 mMK-Pipes
[pH 6.9]) to 200 mM and incubated at 37C for 30 min to initiate polymerization.
Microtubules were then pelleted at 16,000 g for 5 min and briefly washed with
assembly buffer (1 mM GMPCPP, 100 mM KCl, 10 mM K-PIPES, 1 mMMgCl2
[pH 6.9]) containing either docetaxel (125 mM), laulimalide (125 mM), docetaxel
and laulimalide together (125 mM each), or simply the assembly buffer.
A volume of assembly buffer (with or without ligand at the above concentra-
tions) was then added, and the samples were placed on ice for 30 min to
induce depolymerization, yielding a protein concentration of 60 mM. The
samples were separated into four 10 ml fractions and held on ice until analysis.
Prior to mass shift perturbation measurements, an aliquot was incubated at
37C for 30 min to induce (or complete) tubulin polymerization. Sample
temperature was reduced to 20C over 1 min, and the protein was labeled
with the addition of D2O (25% v/v labeling) at this temperature for 4 min.
Previous studies confirmed that labeling was essentially complete by this725–734, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 731
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Laulimalide Binding Modetime (Huzil et al., 2008). Labeling was quenched by adding the sample to a
chilled slurry of immobilized pepsin (Pierce) in 0.1M glycine-hydrochloride
(pH 2.3), and labeled tubulin was digested for 2.5 min on ice. Digestion was
terminated upon centrifugation of the slurry, and an aliquot of the supernatant
was injected into the LC-MS system for analysis, as described elsewhere
(Huzil et al., 2008). All deuterationmeasurements were performed in quadrupli-
cate. Sequence coverages of 94% for a-tubulin and 94% for b-tubulin were
achieved for this study through the detection of 136 peptides, as described
previously in detail (Bennett et al., 2009; Huzil et al., 2008). Residue numbering
is based upon bovine a-tubulin isoform I-C (UniProt P81948) and bovine
b-tubulin isoform II-B (UniProt Q6B856).
Data Analysis
Average deuterium incorporation for all verified peptide sequences was deter-
mined using Hydra, a software package developed in-house for interrogating
large sets of LC-MS and LC-MS/MS data (Slysz et al., 2009). Ligand-induced
mass shift perturbations were quantitated for all combinations of the microtu-
bule control, laulimalide-stabilized, docetaxel-stabilized, and doubly stabilized
microtubules. Shift perturbations were considered significant provided the
following criteria were met: passing a two-tailed t test (p < 0.05) using pooled
standard deviations from quadruplicate analyses of each state; passing a
distribution analysis to guard against spectral overlap (Chik et al., 2006); and
exceeding a threshold shift value (±2 SD) based on a measurement of the shift
noise and assuming its normal distribution. Selections were facilitated by
the generation of two-dimensional DD versus 1-p plots. These plots aid in
identifying peptides bearing significant shift data, avoiding determinations of
significance on the basis of DD alone, and further serve to assess the overall
quality of the MSP analysis.
The levels of altered deuteration were color coded per peptide on the linear
sequence and the relevant tubulin structure (PDB 1JFF or resulting from MD
simulations). Tubulin structures were rendered in all figures using Pymol
(http://pymol.sourceforge.net). To determine the binding site for laulimalide,
a comparison of the mass shift data arising from both the singly, and doubly
ligated microtubules was formalized as described in the Supplemental
Experimental Procedures.
Tubulin Assembly Assay
The assembly synergy of laulimalide and docetaxel on polymer assembly was
investigated using 10 mM tubulin, the addition of laulimalide, and docetaxel
individually (40 mM) and combined (20 mM each). Microtubule assembly was
monitored turbidimetrically using a temperature controlled Varian Cary
50 UV-Vis spectrophotometer at 350 nm, following the method of Gapud
et al., (2004). All assay components except ligand were added to a cuvette
held at 10C. Ligand was then added and assembly monitored for 1 hr at 10C.
Laulimalide Conformer Library Generation and Conformer Docking
Absolute Cartesian coordinates for each of the fifteen solution conformers
of laulimalide were obtained from supplementary information included in
Thepchatri et al., (2005). These files were converted to xyz coordinates for
subsequent import into JChem Standardizer (Chemaxon Inc.), where explicit
hydrogen atoms and bond orders were set. These files were then exported
into the mol2 format and imported into MarvinSketch (Chemaxon Inc.) using
3D transformation. The 15 seed conformers were subjected to conformer
proliferation using the conformers tool in MarvinSketch. Default settings
were chosen, the only exception being that the lowest energy conformer
was not calculated, permitting instead the generation of 100 diverse
conformers per starting conformer, producing a library of 1515 molecules for
subsequent screening with AUTODOCK version 4.0. Details are provided in
the Supplemental Experimental Procedures, including the procedure for blind
docking of the top-ranked poses resulting from these activities.
Molecular Dynamics Simulations and Conformational Clustering
All Molecular Dynamics (MD) simulations were carried out using the NAMD
program at a mean temperature of 310K and physiological pH (pH 7.0) using
the all-hydrogen AMBER99SB force field. Details are provided in Supple-
mental Experimental Procedures. MD simulations on the laulimalide-tubulin
complex produced numerous structures that explored its conformational
space. A common approach to extract dominant conformations sampled732 Chemistry & Biology 17, 725–734, July 30, 2010 ª2010 Elsevier Lduring the MD simulation is to perform RMSD conformational clustering on
the whole trajectory (Shao et al., 2007). To generate a reduced set of represen-
tative laulimalide-tubulin models, we performed RMSD conformational clus-
tering with the average-linkage algorithm as implemented in the PTRAJ utility
of AMBER10 using cluster counts ranging from 1 to 30 clusters. Structures
were extracted at 2 ps intervals over the entire simulation. All Ca-atoms
were RMSD fitted to the minimized initial structure in order to remove overall
rotation and translation. RMSD-clustering was performed on laulimalide along
with tubulin residues that are located within 10A˚ of the ligand. The selected
system was clustered into groups of similar conformations using the atom-
positional RMSD of all atoms, including side chains and hydrogen atoms, as
the similarity criterion. The optimal number of clusters was chosen based on
two clustering metrics, the Davies-Bouldin index (DBI) and the ‘‘elbow
criterion’’ (Shao et al., 2007).
Binding Energy Analysis
Binding free energies were calculated using the molecular mechanics
Poisson-Boltzmann surface area (MM-PBSA) method as implemented in
AMBER10 and described in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/
j.chembiol.2010.05.019.
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